Pär‐Ola Bendahl
Lund University(SE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Cancer Genomics and Diagnostics, Breast Lesions and Carcinomas
Most-Cited Works
- → Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients(2002)602 cited
- → The CD44+/CD24-phenotype is enriched in basal-like breast tumors(2008)552 cited
- → Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity(2007)521 cited
- → Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease(2015)449 cited
- → Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial(2013)234 cited
- Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.(2002)
- → Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative(2018)204 cited
- → CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers(2011)201 cited
- → Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy(2015)191 cited
- → Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma(2007)179 cited